Munching on melamine may harm kidney health

NewsGuard 100/100 Score

By Helen Albert, Senior medwireNews Reporter

Eating hot food off melamine plates appears to result in significant melamine leaching into the digestive system, suggest findings from a small study.

As reported in JAMA Internal Medicine, Ming-Tsang Wu (Kaohsiung Medical University Hospital, Taiwan) and colleagues compared urinary excretion of melamine after consumption of hot noodle soup in melamine or ceramic bowls over a 12-hour period.

The total melamine excretion over 12 hours in the melamine group was 8.35 µg versus 1.31 µg in the ceramic group, a statistically significant difference.

Although only carried out in a small number of people, the findings of this study are concerning, as continuous low-dose melamine exposure can cause urolithiasis in children and adults, note the authors. For example, the 2008 melamine-tainted baby formula incident caused six deaths and around 50,000 hospitalizations.

Taiwan has a particularly high incidence of kidney stones and the possibility that this may be linked to high melamine exposure prompted Wu et al to carry out this research.

In total, 12 men and women aged 20-27 years took part in the study, which was carried out in a crossover fashion such that six participants initially ate from either melamine bowls or ceramic bowls and then swapped over after a 3-week washout period.

The researchers collected a mean of 4.3 urine samples over the 12 hours after soup consumption from melamine and from ceramic bowls.

"Melamine tableware may release large amounts of melamine when used to serve high-temperature foods," say Wu and co-authors.

However, they note that "the amount of melamine released into food and beverages from melamine tableware varies by brand, so the results of this study of one brand may not be generalized to other brands."

They conclude that although it is not yet clear what levels of urinary melamine are of clinical concern, "the consequences of long-term melamine exposure still should be of concern."

Licensed from medwireNews with permission from Springer Healthcare Ltd. ©Springer Healthcare Ltd. All rights reserved. Neither of these parties endorse or recommend any commercial products, services, or equipment.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Phase 3 trial shows overall survival benefit from adjuvant therapy in kidney cancer patients